Mr. Srikanth Sasidhar is the Chief Financial Officer at Jeevan Scientific.
He has more than 8 years of varied experience in the Accounting, Taxation, Audit & Cost Management in manufacturing, Retail & Export Oriented Units.
Prior to joining Jeevan Scientific, he was associated with Orient Cements Limited, Mahavir Motors, & Apex Frozen Foods Limited.
Mr. Srikanth is a Fellow Member of The Institute of Chartered Accountants of India, a Member of The Institute of Cost Accountants of India and holds a Bachelor of Commerce (Taxation) From Acharya Nagarjuna University.
Mr. Naidu is Vice President - Operations at Jeevan Scientific Technology Limited (JSTL) and having more than 20 years’ of professional experience in Clinical Research and Pharma Companies. He has been associated with JSTL since 2014. Before joining JSTL, he was associated with Azidus Laboratories, Actimus Bio, RA Chem Pharma in heading different portfolios including Clinical, Bioanalytical and Quality Assurance.
He has a successful track record in handling of BA/BE operations and CT management and excellence in technical, client relationship management and people management skills.
He has played a significant role in the development, implementation of Quality Management Systems in several CROs and making them of global standards. He also has rich professional experience in handling various regulatory inspections USFDA, WHO, ANVISA, MHRA, MoH Turkey, NPCB, CAP, NABL, and CDSCO.
Mr. Naidu is responsible for organizing and implementing operational strategies for all BA/BE studies at Jeevan Scientific.
Mr. Ravi Vadlamudi is head of Bioanalytical Research at Jeevan Scientific.
Mr. Ravi has a rich experience of more than 15 years in the field of clinical research. He is expertise in organizing, developing and implementing technical strategies in bioanalytical research especially handling large molecules.
Prior to Jeevan Scientific, he was associated with Lupin Bioresearch Center, Lambda Therapeutics, Admerus Biosciences, and RA Chem Pharma with vast experience in handling complex folios Contraceptives, Endogenous compounds, Vitamins, Steroids, hormonal drugs, synthetic hormones, corticosteroids, Nasal Spray, Inhalation products and peptides. He has hands on experience in handling end to end operations in BA/BE studies. He also has professional experience in facing different regulatory audits USFDA, MHRA, AFSSAPS and CDSCO. He is a professional with technical, people management and client relationship skills.
Mr. Ravi is responsible for overall Bioanalytical Research activities in JSTL.
Mr. Daniel Rapaka holds a Master's degree in Biotechnology from Madras University as well as a Masters of Business Administration from Osmania University. He has prior experience of over 17 years in Business Development in CRO & Pharma industry.
Mr. Daniel is responsible for Client acquisition, maintaining Client relationships, key Account management, delivering & sustaining business growth, and aligning team as per the Organization's requirement apart from constantly looking for new business opportunities.
Prior to joining JSTL, he was associated with Claris life sciences, Ocimum Bio solutions, Aurobindo Pharma, QPS LLC & JSS Medical research with very good exposure with global pharma companies.
Dr. K. Someswara Rao as Vice President - Clinical Research heads the Clinical Trials department at Jeevan Scientific Technology Limited (JSTL) and is also responsible for organizing and implementing operational strategies for the entire company. He has been associated with JSTL since January 2022 and has more than 19 years of professional experience in Clinical Research and Pharma Companies. Before joining JSTL, he was associated with AXIS Clinicals Ltd, Emcure Pharmaceuticals, Ranbaxy Laboratories, Sun Pharma Advanced Research Centre and Dr. Reddy's Laboratories Ltd., heading different portfolios including clinical pharmacology and biopharmaceutics, pharmacokinetics and biostatistics, medical wiring and clinical research.
Dr. K. Someswara Rao has vast experience in conducting many clinical trials in various therapeutic segments including Oncology, Schizophrenia, Diabetes, Ophthalmics, Arthritis, Diarrhoea, Dermatology, Vaccines, Vasoconstrictor studies, Transdermal Patches, Narcotics, Asthma and Biosimilars, while working in several CROs and Pharma companies and played significant role for the market entry. He has vast experience in conducting bioavailability/bioequivalence studies for orals and other several pharmaceutical dosage forms like Nasal Sprays, Suspensions, Dispersible Tablets, Gels, Creams, Lotions, Ointments, Transdermal Patches, Chewable Tablets, Intravenous or Intramuscular Depot Injections, Liposomal Injections, Skin Irritation and Sensitization studies, Adhesion studies and Narcotics in support of the drug development of IND, NDA, ANDA, and 505(b)2 submission studies. He also has rich professional experience in handling various regulatory inspections such as USFDA, WHO, ANVISA, MHRA, MoH Turkey, French -Affsaps, THAI-FDA GLP, MCC-South Africa, GCC (Gulf Countries Council), Ministry of Health, Kazakhstan and CDSCO
Mr. Sadanandam Eega is the Head - Quality Assurance at Jeevan Scientific Technology Limited. He has around 18 years of experience in Quality Assurance in the domains of Bioavailability and Bioequivalence (BA/BE), Preclinical, clinical trial studies and Pharmacovigilance. He is also a well-versed auditor in compliance with applicable GCP/GLP regulations and drug regulatory affairs.
Mr. Sadanandam in his career has faced over 50+ national and international regulatory inspections like USFDA, UK-MHRA, FRENCH, WHO, ANVISA, NPRA-MALAYSIA, MOH-BELAURUS, SFDA, MCC-SOUTH AFRICA, CDSCO-DCG(I), DMHO, NABL (ISO 15189: 2012) and ISO 9001:2015 (UKAS).
He is associated with JSTL since Jan 2022 and prior to that he worked with Aizant Drug Research, Actimus Bio, NEKTAR Therapeutics and Aurobindo. At JSTL, as a QA Head he is responsible for QMS maintenance, continual improvement of quality systems, automation, managing client audits, regulatory inspections and other QA functions, as well as assuring that the conduct of clinical research studies is in accordance with ICH GCP, OECD GLP and applicable regulations/guidelines and SOPs.
Dr. Srinivasa Rao is Incharge of Clinical Trials, at JSTL. He has 20 yrs. of experience, both as Physician & Pharmaceutical industry professional. His career includes overseas experience in natural product drug discovery & development, IND development & NDA Submission in India, Preclinical drug development for USFDA, Clinical research, Competetive intelligence, Pharmaceutical asset licensing, Business Strategy, Intellectual property rights & Consumer product development.
He is responsible for the conduct of clinical trials at JSTL.